Nkarta Therapeutics Stock

nkartatx.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $125MM

Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer.

Register To Buy and Sell Shares

For more details on financing and valuation for Nkarta Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Nkarta Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Nkarta Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Paul Hastings
Founder, Chief Executive Officer & Board Member
Matthew Plunkett Ph.D
Chief Financial Officer and Senior Vice President
Dario Campana MD
Scientific Founder
Kanya Rajangam Ph.D
Chief Medical Officer and Senior Vice President
James Trager Ph.D
Senior Vice President and Chief Scientific Officer

Board Members

Jill Carroll
SR One
Michael Dybbs Ph.D
Samsara BioCapital
Fouad Azzam Ph.D
Life Sciences Partners
Paul Hastings
Ali Behbahani MD
New Enterprise Associates
Tiba Aynechi Ph.D
Novo Holdings

Frequently Asked Questions About Nkarta Therapeutics’ Stock

plusminus
Can you buy Nkarta Therapeutics’ stock?
Nkarta Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Nkarta Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Nkarta Therapeutics’ stock?
Yes, you can sell stock of a private company like Nkarta Therapeutics. Forge can help you sell your Nkarta Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Nkarta Therapeutics’ stock price?
Nkarta Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Nkarta Therapeutics’ private market stock price with Forge Data.
plusminus
What is Nkarta Therapeutics’ stock ticker symbol?
Nkarta Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development | BioSpace
Nkarta Therapeutics Expands Senior Management Team with Key Hires in Finance and Clinical Development - read this article along with other careers information, tips and advice on BioSpace
Biopharmaceutical Company Nkarta Therapeutics Raises $114 Million
Nkarta Therapeutics announced it has raised $114 million in Series B funding led by new investor Samsara BioCapital.
Updated on: Apr 19, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.